| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/02770903.2014.917659 |
| P698 | PubMed publication ID | 24796647 |
| P50 | author | Peter J. Barnes | Q7174846 |
| Ian M. Adcock | Q38803002 | ||
| P2093 | author name string | Lingling Li | |
| Wei Gao | |||
| Dandan Wu | |||
| Mao Huang | |||
| Xin Yao | |||
| Ji Zhou | |||
| Hui Bi | |||
| P2860 | cites work | The role of chemokines in exercise-induced bronchoconstriction in asthma. | Q54595036 |
| IL-12 regulates bone marrow eosinophilia and airway eotaxin levels induced by airway allergen exposure | Q57085053 | ||
| The Effect of IL-5 and Eotaxin Expression in the Lung on Eosinophil Trafficking and Degranulation and the Induction of Bronchial Hyperreactivity | Q57693315 | ||
| Comparison of plasma eotaxin family level in aspirin-induced and aspirin-tolerant asthma patients | Q28193499 | ||
| Eotaxin and the attraction of eosinophils to the asthmatic lung | Q28362893 | ||
| Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
| Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients | Q34088102 | ||
| The indication and effectiveness of low-dose erythromycin therapy in pediatric patients with bronchial asthma | Q34186784 | ||
| Eosinophil chemokines and chemokine receptors: their role in eosinophil accumulation and activation in asthma and potential as therapeutic targets | Q34471913 | ||
| Effect of influenza vaccinations on immune response and serum eotaxin level in patients with allergic bronchial asthma | Q35609133 | ||
| Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function | Q35609691 | ||
| Asthma: defining of the persistent adult phenotypes | Q36578781 | ||
| Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids | Q37365764 | ||
| The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation | Q37505217 | ||
| A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). | Q37799451 | ||
| Hydrogen peroxide in exhaled breath condensate in patients with asthma: a promising biomarker? | Q37857558 | ||
| Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation. | Q39123151 | ||
| beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. | Q40406054 | ||
| Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma. | Q42442862 | ||
| Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids | Q43517296 | ||
| Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. | Q44247874 | ||
| Association of interleukin-5 and eotaxin with acute exacerbation of asthma | Q44547698 | ||
| Smoking affects eotaxin levels in asthma patients | Q44704638 | ||
| "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids | Q44950357 | ||
| Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa | Q45254349 | ||
| Inflammatory biomarkers in airways of patients with severe asthma compared with non-severe asthma. | Q45923952 | ||
| Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids | Q46418165 | ||
| Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations | Q46968826 | ||
| Effect of exercise training on plasma visfatin and eotaxin levels | Q46983590 | ||
| Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial | Q47249808 | ||
| Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients. | Q47660247 | ||
| Concentration of CCL11, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation | Q47734926 | ||
| Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum. | Q47999363 | ||
| Eotaxin level in induced sputum is increased in patients with bronchial asthma and in smokers | Q48029452 | ||
| Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. | Q51673100 | ||
| Plasma brain-derived neurotrophic factor levels are associated with clinical severity in school age children with asthma. | Q51750573 | ||
| Markers of eosinophilic and neutrophilic inflammation in bronchoalveolar lavage of asthmatic and atopic children. | Q51795171 | ||
| Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. | Q52043452 | ||
| Differences in airway cytokine profile in severe asthma compared to moderate asthma. | Q53511586 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| diagnostic marker | Q129938486 | ||
| P304 | page(s) | 847-854 | |
| P577 | publication date | 2014-05-13 | |
| P1433 | published in | Journal of Asthma | Q2603603 |
| P1476 | title | CCL11 as a potential diagnostic marker for asthma? | |
| P478 | volume | 51 |
| Q48301160 | 1,6-O,O-Diacetylbritannilactone Inhibits Eotaxin-1 and ALOX15 Expression Through Inactivation of STAT6 in A549 Cells. |
| Q44048776 | Associations between Th17-related inflammatory cytokines and asthma in adults: A Case-Control Study |
| Q97094026 | Berberine Inhibits Pro-inflammatory Cytokine-induced IL-6 and CCL11 Production via Modulation of STAT6 Pathway in Human Bronchial Epithelial Cells |
| Q26782718 | Biomarkers and severe asthma: a critical appraisal |
| Q41241896 | Bronchial hyperreactivity in perimenstrual asthma is associated with increased Th-2 response in lower airways |
| Q35904502 | Bronchial lesions of mouse model of asthma are preceded by immune complex vasculitis and induced bronchial associated lymphoid tissue (iBALT). |
| Q38679996 | CCL11, a novel mediator of inflammatory bone resorption |
| Q95831538 | CCR3 antagonist protects against induced cellular senescence and promotes rejuvenation in periodontal ligament cells for stimulating pulp regeneration in the aged dog |
| Q41626482 | Characteristics of Proinflammatory Cytokines and Chemokines in Airways of Asthmatics: Relationships with Disease Severity and Infiltration of Inflammatory Cells |
| Q47671981 | Characterization of the acute inflammatory profile and resolution of airway inflammation after Igf1r-gene targeting in a murine model of HDM-induced asthma. |
| Q26783095 | Deciphering Asthma Biomarkers with Protein Profiling Technology |
| Q34784852 | Directional secretory response of double stranded RNA-induced thymic stromal lymphopoetin (TSLP) and CCL11/eotaxin-1 in human asthmatic airways |
| Q36904539 | Effects of aerobic exercise training on peripheral brain-derived neurotrophic factor and eotaxin-1 levels in obese young men. |
| Q28546581 | Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood |
| Q92786997 | Expression of eosinophil β chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma |
| Q35859326 | IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle |
| Q93009864 | Immune network dysregulation associated with child neurodevelopmental delay: modulatory role of prenatal alcohol exposure |
| Q38632790 | Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma? |
| Q28073074 | Personalized Medicine in Allergy |
| Q37592041 | Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity |
| Q40446532 | Plasma cytokines eotaxin, MIP-1α, MCP-4, and vascular endothelial growth factor in acute lower respiratory tract infection |
| Q55353561 | Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders. |
| Q88930595 | Serum CCL11 level is associated with radiographic spinal damage in patients with ankylosing spondylitis |
| Q98895130 | Serum levels of chemokines in adolescents with major depression treated with fluoxetine |
| Q49201946 | Severe bronchial asthma in children: a review of novel biomarkers used as predictors of the disease |
| Q89723982 | TLR5 Activation Exacerbates Airway Inflammation in Asthma |
| Q47994498 | The Flavonoid 7,4'-Dihydroxyflavone Prevents Dexamethasone Paradoxical Adverse Effect on Eotaxin Production by Human Fibroblasts |
| Q38843261 | The path to personalized medicine in asthma. |
| Q55269207 | Urinary polycyclic aromatic hydrocarbon metabolites and adult asthma: a case-control study. |
Search more.